Skip to main content
ACRS logo

ACRS · Aclaris Therapeutics, Inc. · Fails to Deliver

Track ACRS — free
$3.48 -0.02 (-0.57%) Q1 2024 earnings call transcript
Market Cap
$555.14M
Shares
158.61M
Volume · Nov 19 1.89M Avg daily vol (3M) 3.05M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-10-26 4,908 $3.75 $18,405
2026-10-22 4,994 $3.81 $19,027
2026-10-21 999 $3.77 $3,766
2026-10-14 10 $3.47 $35
2026-10-09 706 $3.79 $2,676
2026-10-08 1,799,502 $3.40 $6,118,307
2026-10-06 952 $4.27 $4,065
2026-10-05 61,509 $4.39 $270,025
2026-09-22 90,958 $5.57 $506,636
2026-09-21 16,758 $5.50 $92,169
2026-09-04 895 $5.95 $5,325
2026-09-03 2,369 $6.18 $14,640
2026-09-02 115 $6.02 $692
2026-08-24 336,838 $6.41 $2,159,132
2026-08-20 1 $6.44 $6
Showing 1–15 of 15 settlements
Key facts CIK 1557746 CUSIP 00461U105 13F (30d) 182 filings 159 filers Visit website Investor relations